3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Fatigue
2
Trismus
1
Radiation Injuries
1
Oropharyngeal Neoplasms
1
Multiple Myeloma
1
Mouth Neoplasms
1
Lymphoma, B-Cell
1
Lymphedema
1
Lung Neoplasms
1
Fibrosis
1
Cachexia
1
Anemia
1
Interventions
Cisplatin
18
Specimen Handling
10
Radiotherapy
10
Cetuximab
10
Magnetic Resonance Spectroscopy
9
Radiotherapy, Intensity-Modulated
8
Carboplatin
7
1,2-diaminocyclohexaneplatinum II citrate
7
pembrolizumab
6
Platinum
6
Paclitaxel
5
Drug Therapy
5
Celecoxib
5
cemiplimab
4
X-Rays
4
Surgical Procedures, Operative
4
Radiation
4
Fluorouracil
4
Biopsy
4
Taxes
3
Standard of Care
3
Docetaxel
3
durvalumab
2
Radiotherapy, Image-Guided
2
RRx-001
2
Practice Guidelines as Topic
2
Observation
2
Nivolumab
2
Injections
2
Fenretinide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Mouth Neoplasms
×
Physical Therapy Modalities
×
Clear all
NCT00780312
2013-07-02
HOHF
Rigshospitalet, Denmark
Phase 2
Completed
97 enrolled